Johnson & Johnson Talcum Cancer Case

Introduction to the Case

A Minnesota jury awarded $65.5 million on Friday to a mother of three who claimed talcum products made by Johnson & Johnson exposed her to asbestos and contributed to her developing cancer in the lining of her lungs.
Jurors determined that plaintiff Anna Jean Houghton Carley, 37, should be compensated by Johnson & Johnson after using its baby powder throughout her childhood and later developing mesothelioma, an aggressive cancer caused primarily by exposure to the carcinogen asbestos.
Johnson & Johnson said it would appeal the verdict.

The Trial and Verdict

During a 13-day trial in Ramsey County District Court, Carley’s legal team argued the pharmaceutical giant sold and marketed talc-based products to consumers despite knowing it can be contaminated with asbestos. Carley’s lawyers also said her family was never warned about potential dangers while using the product on their child. The product was taken off shelves in the U.S. in 2020.
“This case was not about compensation only. It was about truth and accountability," Carley’s attorney Ben Braly said.
Erik Haas, worldwide vice president of litigation for Johnson & Johnson, argued the company’s baby powder is safe, does not contain asbestos and does not cause cancer. He expects an appellate court to reverse the decision.

Background and History of the Case

The verdict is the latest development in a longstanding legal battle over claims that talc in Johnson’s Baby Powder and Shower to Shower body powder was connected to ovarian cancer and mesothelioma, which strikes the lungs and other organs. Johnson & Johnson stopped selling powder made with talc worldwide in 2023.
“These lawsuits are predicated on ‘junk science,’ refuted by decades of studies that demonstrate Johnson & Johnson’s Baby Powder is safe, does not contain asbestos and does not cause cancer,” Haas said in a statement after the verdict.
Earlier this month, a Los Angeles jury awarded $40 million to two women who claimed Johnson & Johnson’s talcum powder caused their ovarian cancer. And in October, another California jury ordered the company to pay $966 million to the family of a woman who died of mesothelioma, claiming she developed the cancer because the baby powder she used was contaminated with asbestos.

Conclusion

The Johnson & Johnson talcum cancer case has brought attention to the potential risks associated with using talc-based products. While the company maintains that its products are safe, the jury’s verdict suggests that there may be a link between talc and cancer. As the case continues to unfold, it is likely that more information will come to light about the safety of talc-based products and the potential risks associated with their use.

FAQs

Q: What is the Johnson & Johnson talcum cancer case about?
A: The case is about a mother of three who claimed that Johnson & Johnson’s talcum products exposed her to asbestos and contributed to her developing cancer.
Q: How much was the jury’s verdict?
A: The jury awarded $65.5 million to the plaintiff.
Q: What is mesothelioma?
A: Mesothelioma is an aggressive cancer caused primarily by exposure to the carcinogen asbestos.
Q: Has Johnson & Johnson stopped selling talc-based products?
A: Yes, Johnson & Johnson stopped selling powder made with talc worldwide in 2023.
Q: What is the company’s response to the verdict?
A: Johnson & Johnson said it would appeal the verdict and maintains that its products are safe and do not contain asbestos.